## Abstract ## BACKGROUND: Continuous insulin infusion (CII) to manage hyperglycemia is the accepted standard of care in the intensive care unit (ICU); however, the safety and efficacy of CII in the nonโICU setting has not been determined. ## RESEARCH DESIGN AND METHODS: This is a retrospective
In Response to: Safety and efficacy of continuous insulin infusion in noncritical care settings
โ Scribed by Russell Vinik; Robert C. Pendleton; Robert E. Jones
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 76 KB
- Volume
- 5
- Category
- Article
- ISSN
- 1553-5592
- DOI
- 10.1002/jhm.801
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
We report here five surgeries successfully performed with a continuous infusion of Mononineเฎพ (Armour Pharmaceutical Company, Kankakee, IL) in three hemophilic B patients. Before surgery the patients received a bolus dose of 40 to 100 U/kg according to the type of surgery. This injection was followed
To compare the safety and efficacy of continuous insulin infusion (CII) via a computer-guided and a standard paper form protocol in a medical intensive care unit (ICU). ## METHODS: Multicenter randomized trial of 153 ICU patients randomized to CII using the Glucommander (n ยผ 77) or a standard pap
## Abstract ## BACKGROUND. Interferonโalpha (IFNโฮฑ) confers a survival advantage for the minority of patients with chronic myeloid leukemia (CML) who achieve a complete cytogenetic response. The question of whether IFNโฮฑโresponsive patients can experience further improvements with imatinib has not